VALLITTE valganciclovir (as hydrochloride) 450mg film coated tablet bottle

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

valganciclovir hydrochloride, Quantity: 496.3 mg (Equivalent: valganciclovir, Qty 450 mg)

Saadav alates:

Arrotex Pharmaceuticals Pty Ltd

Ravimvorm:

Tablet, film coated

Koostis:

Excipient Ingredients: croscarmellose sodium; povidone; silicon dioxide; stearic acid; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; iron oxide red; macrogol 400

Manustamisviis:

Oral

Ühikuid pakis:

60

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Valganciclovir is indicated for the treatment of cytomegalovirus (CMV) retinitis in adult patients with acquired immunodeficiency syndrome (AIDS).,Valganciclovir is indicated for the prophylaxis of CMV disease in adult and paediatric solid organ transplantation (SOT) patients who are at risk.

Toote kokkuvõte:

Visual Identification: Pink coloured, oval shaped, biconvex, film-coated tablets with "VLG" debossed on one side and "450" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Registered

Loa andmise kuupäev:

2019-05-16